New anti-obesity pills threaten Eli Lilly and Novo Nordisk’s stock market empire
As more pharmaceutical companies make inroads in the weight loss market, the two firms saw their shares fall more than 10% in the last month
Are European stocks finally outperforming Wall Street?
European share prices started the year on a positive note, trading at lower valuations, but analysts caution against confirming a trend shift
Top 10 pharma companies have over $120 billion in cash for mergers and acquisitions
Drug companies like BMS, GSK and Amgen face revenue losses from patent expirations